在MRGPRX2信号传递过程中涉及lysyl-tRNA合成酶和MITF通路
Yanru Guo1,2, Laia Ollé1,2, Elizabeth Proaño-Pérez1,2,3
1Biochemistry and Molecular Biology Unit, Biomedicine Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Frontiers in immunology
|May 26, 2023
概括
这项研究表明,激活MRGPRX2受体会导致微相关转录因子 (MITF) 活性增加,这对于巨细胞脱粒化至关重要. 抑制这种途径可以治疗与MRGPRX2相关的疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与Mas相关的G蛋白结合受体X2 (MRGPRX2) 参与皮肤免疫,疼痛和非IgE介导的过敏反应.
- MRGPRX2在药物不良反应和炎症性皮肤疾病 (如慢性自发性疹和亚托皮炎) 中发挥作用.
- 在MRGPRX2激活下游的精确信号通路仍然在很大程度上没有特征.
研究的目的:
- 为了阐明瘤细胞中MRGPRX2激活的信号转导通路.
- 为了研究 Lysyl t-RNA 合成酶 (LysRS) 和微光体相关转录因子 (MITF) 在MRGPRX2-介导的巨细胞反应中的作用.
- 探索MRGPRX2相关病理的潜在治疗点.
主要方法:
- 使用P物质研究MRGPRX2激活,并确定了巨细胞的下游信号事件.
- 采用了诸如西式涂抹,流量测试和巨细胞脱粒测试等技术.
- 使用基因沉默 (siRNA) 和药理抑制 (ML329) 来评估MITF的作用.
主要成果:
- 由物质P激活MRGPRX2促进了 Lysyl t-RNA合成酶 (LysRS) 的核转位和激活.
- MRGPRX2信号导致了MITF酸化和增加了MITF活动,这取决于LysRS.
- 用ML329抑制MITF或抑制其通路显著降低了MRGPRX2诱导的流和巨细胞降粒.
- 已知的MRGPRX2-激活药物 (例如,阿特拉库里,万科米辛,吗啡) 也增加了MITF活性.
结论:
- MRGPRX2信号激活了LysRS-MITF通路,导致巨细胞脱粒化.
- 在MRGPRX2-依赖性巨细胞反应中,MITF起到关键的调解作用.
- 针对MITF途径为涉及MRGPRX2激活的疾病提供了潜在的治疗策略.
相关概念视频
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
TGF - β Signaling Pathway
7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


